Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
Key Details
- 1More than 30 Mayo Clinic studies will be featured at the 2026 ASCO Annual Meeting.
- 2Highlighted topics include precision oncology, early cancer detection, and AI-driven analysis.
- 3A deep learning approach will be presented to quantify tumor microenvironment features in colon cancer trials.
- 4Research includes multicancer early detection testing and biomarker-driven treatments for various cancers.
- 5Specific sessions will address AI-enabled analysis of postoperative ctDNA status and clinical outcomes.
Why It Matters
Presentations on AI-powered tissue analysis and early detection signal accelerating integration of imaging AI into oncology care. Such advances can inform best practices for radiologists and collaborative cancer care teams.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.